Embodied Conversational Agents for CervicalCancer Screening Abnormalities

Many people who receive abnormal results from cervical cancer screening do not follow up with appointments that would allow treatment of precancer and would prevent cancer. In this project, we will develop an animated health coach that works on a smartphone to guide them through the cervical cancer screening and care process to ensure they receive the follow up and treatment they need to prevent cancer.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cervical Cancer Screening

Age range

21 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 21-65
has an abnormal cervical cancer screening test result
able to read in English or Spanish

Exclusion criteria

planning to move out of the study area during the follow up period
pregnant
incarcerated
dose not have adequate vision or hearing to use the app
diagnosed with cervical cancer

Treatment and study plan

embodied conversational agents for cervical cancer prevention

Behavioral

People receiving the intervention will receive an animated health coach that works on a smartphone to guide them through the cervical cancer screening and care process to ensure they receive the follow up and treatment they need to prevent cancer.

Primary outcomes

The proportion of participants who receive recommended follow-up testing and treatment.

Time frame: 18 months

Study contacts

Contact information is provided by the study sponsor or research team.

ECA-CCSA Research Coordinator

CONTACT

[email protected]

617-651-9410

Sponsors and collaborators

Lead sponsor

Tufts Medical Center

Other

Collaborators

National Cancer Institute (NCI)

Registry information

Official study title

Embodied Conversational Agents for Cervical Cancer Screening Abnormalities

Acronym: ECA-CCSA

Important dates

Study start: 2026
Primary completion: 2028
Study completion: 2029
First posted: Aug 31, 2026
Registry last updated: Sep 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not yet recruiting